CD8A and neoplasm: Consistently, the small molecule PERK inhibitor AMG-44 reduced the immunosuppressive activity of MDSCs, promoted the expansion of tumor infiltrating CD8 + T cells expressing interferon gamma (IFNγ) and synergized with anti-PD-L1 ICI [180].